Dictionary

allow_url_fopen is ENABLED Dictionary Search

exon

Synonyms

Noun

1. coding DNA

2. deoxyribonucleic acid, desoxyribonucleic acid, DNA

Usage
Activation of cryptic donor splice site due to an exonic MYPN variant in congenital myopathy - Nature
Sunvozertinib Outperforms Chemotherapy as First-Line Therapy for EGFR Exon 20–Mutant NSCLC - Targeted Oncology
Sunvozertinib in NSCLC With EGFR Exon 20 Insertion Mutations - The ASCO Post
Ascidian and Lilly Enter Global Research Collaboration to Develop RNA Exon Editors for Devastating Kidney Diseases - PR Newswire
Emerging TKIs Drive Renewed Progress in EGFR Exon 20 Insertion–Positive NSCLC - OncLive
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases - Genetic Engineering and Biotechnology News
Dyne Submits BLA for Z-Rostudirsen in Exon 51 Skipping Duchenne Muscular Dystrophy - NeurologyLive
Houston Dynamo FC loan forward Exon Arzú to Real C.D. España in Honduras - Houston Dynamo FC
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53® - Sarepta Therapeutics
Exonerating the exon: what happens when the genome loses its instructions? - Wellcome Sanger Institute Blog
Kansas Supreme Court upholds Exon’s conviction in daughter’s death - WIBW
Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics - Nature
Sunvozertinib Shows Superior Efficacy vs Chemo in Frontline Advanced EGFR Exon 20+ NSCLC - OncLive
FDA Accepts NDA for Zipalertinib in EGFR Exon 20-Mutant Lung Cancer - Targeted Oncology
DMD Treatment Toolkit: Corticosteroids, Exon Skipping, and Gene Therapy - NeurologyLive
Phylogenomic profile of exon-intron organization across angiosperms, their relationships with protein domains, and functional implications - Nature
FDA Accepts NDA for Zipalertinib in Locally Advanced or Metastatic EGFR Exon 20+ NSCLC - OncLive
A portable poison exon for small-molecule control of mammalian gene expression - Nature
Sunvozertinib Monotherapy Bests Platinum-Doublet Chemotherapy in EGFR Exon 20+ NSCLC - OncLive
Recombinant GBA1 alleles presenting as exon-level deletions by short-read NGS in Parkinson disease: Implications for diagnostic approaches - Nature
MET and Lung Cancer - American Lung Association
Lilly, Ascidian link up in RNA exon editing pact - BioPharma Dive
Lilly targets kidney disease with Ascidian’s RNA exon editors for up to $1.9B - BioSpace
Sarepta’s DMD Exon-Skippers Fail Confirmatory Study, Stock Craters - BioSpace
The Landscape of EGFR Exon 20-Positive Lung Cancer Treatment - Targeted Oncology
Gene regulation through exon junction complex modularity - Nature
Exceptional response to furmonertinib in lung adenocarcinoma harboring HER2 exon 20 insertion mutation: a case report - Frontiers
Hoth Therapeutics Receives U.S. Notice of Allowance for Novel Exon-Skipping Therapy Targeting Allergic Diseases - PR Newswire
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity - Nature
Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC - AJMC
Dyne Plans Post-Prasad FDA Run as Duchenne Exon Skipper Sustains Benefit in Long Term Data - BioSpace
Acyclovir-Activated Poison Exon Enables Reversible Gene Expression - Genetic Engineering and Biotechnology News
Andamertinib Effective in NSCLC With EGFR Exon 20 Insertion Mutation - AJMC
Rolling NDA Submission Begins for Zipalertinib in EGFR Exon 20+ NSCLC - Targeted Oncology
SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activation - Nature
Genetic and clinical characteristics of Japanese cystinuria with exon and exon–intron boundary variants - Nature
EGFR and Lung Cancer - American Lung Association
Targeted Strategies Push the Envelope for BRAF V600E–, MET Exon 14–, and KRAS G12C–Mutated Metastatic NSCLC - OncLive
Sarepta Plans FDA Run for Duchenne Exon Skippers Despite Confirmatory Trial Failure - BioSpace
EGFR Exon 19 Deletion NSCLC With MET Amplification and TP53 Mutation: What Is the Optimal First-Line Approach? - CancerNetwork
Dyne readies FDA push after DMD exon 51 med excels in trial - Fierce Biotech
Dyne’s Exon Skipper Delivers ‘Best Ever’ Functional Outcomes in Early DMD Study - BioSpace
Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing - Nature
Sunvozertinib Approval Fills Treatment Gap in Pretreated EGFR Exon 20–Mutant NSCLC - OncLive
INCA033989 With/Without Ruxolitinib Drives Spleen and Anemia Responses in CALR Exon 9–Mutated Myelofibrosis - OncLive
Safety and Synergy of Capmatinib Plus Stereotactic Radiotherapy in MET Exon 14-Mutated Non-Small Cell Lung Cancer: A Case Report - Cureus
Analyses of exon 4a structure reveal the properties of Big tau related to distribution, function and aggregation - Frontiers
Exon-skipping approach boosts levels of key Rett syndrome protein - The Transmitter
PYM1 limits non-canonical Exon Junction Complex occupancy in a gene architecture dependent manner to tune mRNA expression - Nature
Application of Exon Primed Intron Crossing Markers to Cross-Amplify Oreochromis Species in Eastern Africa - Wiley Online Library
RYR2 Exon 3 Deletion as a Cause of Convergent Catecholaminergic Polymorphic Ventricular Tachycardia and Cardiomyopathy - American Heart Association Journals
Alternative Splicing of Exon 23a in Neurofibromatosis Type 1 Pre-mRNA: Its Contribution to the Protein Structure and Function of Neurofibromin - Wiley Interdisciplinary Reviews
Long-read RNA sequencing unveils a novel cryptic exon in MNAT1 along with its full-length transcript structure in TDP-43 proteinopathy - Nature
Sporadic ALS induced pluripotent stem cell derived neurons reveal hallmarks of TDP-43 loss of function - Nature
DOLPHIN advances single-cell transcriptomics beyond gene level by leveraging exon and junction reads - Nature
FDA Grants Accelerated Approval to Sunvozertinib for Metastatic NSCLC With EGFR Exon 20 Insertion Mutations - OncLive
FDA Grants Accelerated Approval to Sunvozertinib for Metastatic NSCLC With EGFR Exon 20 Insertion Mutations - The ASCO Post
Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model - Nature
DG9 boosts PMO nuclear uptake and exon skipping to restore dystrophic muscle and cardiac function - Nature
Structural insights into the cross-exon to cross-intron spliceosome switch - Nature
Houston Dynamo FC sign Honduran National Team attacker Exon Arzú on full transfer from Real C.D. España - Houston Dynamo FC
DMD treatment: Exon-skipping therapies - Muscular Dystrophy News
Recent Developments in Targeting EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer - ASCO Daily News
Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease - Nature
Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib | Leukemia - Nature
Academia Sinica - Research Findings | New mechanistic insights into Prp22-mediated exon ligation and mRNA release - sinica.edu.tw
Regulation of micro- and small-exon retention and other splicing processes by GRP20 for flower development - Nature
EGFR Therapies Fail to Benefit Patients With NSCLC and Exon 20 Insertions - Targeted Oncology
MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience - Nature
EGFR Exon 20 Lung Cancer – New Treatment Options and Detection Methods - American Lung Association
Differential exon usage of developmental genes is associated with deregulated epigenetic marks - Nature
Exon architecture controls mRNA m6A suppression and gene expression - Science | AAAS
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters - Nature
Takeda to Voluntarily Withdraw Mobocertinib for EGFR Exon 20 Insertion+ NSCLC - OncLive
Structural insights into human exon-defined spliceosome prior to activation - Cell Research - Nature
Zipalertinib Shows Promise in Heavily Pretreated EGFR Exon 20-Mutated NSCLC - Targeted Oncology
Exon junction complex shapes the m - Nature
Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue - Nature
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial - The Lancet
Recurrent exon-deleting activating mutations in AHR act as drivers of urinary tract cancer - Nature
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease - PNAS
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5 - Nature
Exon-variant interplay and multi-modal evidence identify endocrine dysregulation in severe psychiatric disorders impacting excitatory neurons | Translational Psychiatry - Nature
Template-jumping prime editing enables large insertion and exon rewriting in vivo - Nature
Exon-junction complex association with stalled ribosomes and slow translation-independent disassembly - Nature
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations - The New England Journal of Medicine
Alternatively spliced mini-exon B in PTPδ regulates excitatory synapses through cell-type-specific trans-synaptic PTPδ-IL1RAP interaction - Nature
Novel FBN1 intron variant causes isolated ectopia lentis via in-frame exon skipping - Nature
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions - The New England Journal of Medicine
Case 2: Treatment Options in Exon 9–Mutated GIST - Targeted Oncology
TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A - Nature
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing - Science | AAAS
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment - Nature
Savolitinib Earns Full Approval in China for Locally Advanced/Metastatic MET Exon 14+ NSCLC - OncLive
A second hotspot for pathogenic exon-skipping variants in CDC45 | European Journal of Human Genetics - Nature
Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer - The New England Journal of Medicine
FDA Grants Breakthrough Therapy Designation to First-Line Sunvozertinib for EGFR Exon 20+ NSCLC - OncLive
The same genomic variants in the first three exons of KANSL1 can be either benign or causative of Koolen-de Vries syndrome: Definition of a validation procedure - ScienceDirect.com
Impact of Exon 1 polymorphism in the MBL2 gene on MBL serum levels and infection susceptibility in acute lymphoid leukemia - Nature
FDA Approves Frontline Amivantamab Plus Chemo for EGFR Exon 20 Insertion+ NSCLC - OncLive
Foreign Language Equivalents
Foreign Language Equivalents of 'exon'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
exno,   wxon,   exoon,   exxon,   ezon,   exn,   exo,   exin,   exonn,   rxon,   econ,   expn,   exom,   xon,   eexon,   eoxn,   exob,   xeon,   eon
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z